Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
42
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Upregulation of long noncoding RNA LOC440040 promotes tumor progression and predicts poor prognosis in patients with prostate cancer

Cheng Zhang1 Department of Urology, Gaoyou Traditional Chinese Medicine Hospital, Yangzhou 225600;2 Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029
,
Chunlin Liu3 Department of Urology, The Second People’s Hospital of Taizhou, Taizhou, Jiangsu, 225500
,
Jie Wu2 Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029;4 Department of Urology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing 211100, People’s Republic of China
,
Yuxiao Zheng2 Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029
,
Haoxiang Xu2 Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029
,
Gong Cheng2 Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029Correspondence[email protected]
&
Lixin Hua2 Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029Correspondence[email protected]
 show all
Pages 4945-4954 | Published online: 11 Oct 2017

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Juan Cai, Xueliang Zuo, Zhiqiang Chen, Wenying Zhao, Yiping Zhu, Zhengxiang Zhang & Xiaobing Ye. (2018) Prognostic value and clinical significance of long noncoding RNA CASC2 in human malignancies: a meta-analysis. Cancer Management and Research 10, pages 1403-1412.
Read now
Wei Lu, Xiaohua Tao, Yibin Fan, Yi Tang, Xin Xu, Shasha Fan, Youming Huang, Yong Yu & Dan Luo. (2018) LINC00888 promoted tumorigenicity of melanoma via miR-126/CRK signaling axis. OncoTargets and Therapy 11, pages 4431-4442.
Read now

Articles from other publishers (6)

Ying-Ying Zhao, Qian-Ming Xiang, Jia-Li Chen, Li Zhang, Wei-Long Zheng, Di Ke, Rong-Shu Shi & Kong-Wu Yang. (2022) SLC25A25-AS1 over-expression could be predicted the dismal prognosis and was related to the immune microenvironment in prostate cancer. Frontiers in Oncology 12.
Crossref
Zeinab Bagheri & Mohammad-Hassan Arjmand. (2021) Prognostic Value of Long Non-coding RNAs in Urological Malignancies: A Systematic Review, and Meta-Analysis. The Open Biomarkers Journal 11:1, pages 115-125.
Crossref
Jinjun Ye, Jidong Liu, Tao Tang, Le Xin, Xing Bao & Yukuang Yan. (2021) miR‑4306 inhibits the malignant behaviors of colorectal cancer by regulating lncRNA FoxD2‑AS1. Molecular Medicine Reports 24:4.
Crossref
Marvin Lim, Anne-Marie Baird, John Aird, John Greene, Dhruv Kapoor, Steven Gray, Ray McDermott & Stephen Finn. (2018) RNAs as Candidate Diagnostic and Prognostic Markers of Prostate Cancer—From Cell Line Models to Liquid Biopsies. Diagnostics 8:3, pages 60.
Crossref
Honggang Qi, Bifeng Wen, Qihang Wu, Wei Cheng, Jiangyong Lou, Junjun Wei, Jianjun Huang, Xuping Yao & Guobin Weng. (2018) Long noncoding RNA SNHG7 accelerates prostate cancer proliferation and cycle progression through cyclin D1 by sponging miR-503. Biomedicine & Pharmacotherapy 102, pages 326-332.
Crossref
John Aird, Anne-Marie Baird, Marvin C.J. Lim, Ray McDermott, Stephen P. Finn & Steven G. Gray. (2018) Carcinogenesis in prostate cancer: The role of long non-coding RNAs. Non-coding RNA Research 3:1, pages 29-38.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.